US faces hurdles as TPP talks intensify
This article was originally published in SRA
Talks on the Trans-Pacific Partnership (TPP) have been going on for around three years, but the public is little wiser now on what's being discussed than when they first started. In the history of free trade agreements, never has so little been known about so much by so many.
You may also be interested in...
Japanese major links with new partners in European consortium to progress first-in-class molecule for multiple hematological malignancies.
A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.
US research-based association says move to annual drug repricing undermines country’s recent efforts to support innovation and again calls for inclusive discussions around broad health system reforms to create funding headroom.